How are vacancies for tax professionals faring amidst the recent political and economic challenges? What are the sectors most in-demand? Which regions are growing, and which firms are experiencing the fastest growth in England and Wales? Download our new report to find out.
Written in partnership with Morgan McKinley, this report analyses the recruitment of tax professionals within and outside the UK’s Accounting sector. It observes the annual and monthly totals trends, compares the most wanted sectors, a regional breakdown of recruitment, and the hiring activity of top firms.
Key findings include:
- Vacancies show consistency rather than buoyant growth throughout 2022
- London is the dominant hirer for the Tax Division and all Accountancy outside Tax
- The Banking sector is the most sought-after for tax vacancies in 2022
- The Kier Group tops the table with the biggest numbers year-to-date
- The Big Four is present with PwC, which takes the runner-up within Accountancy
To discover more insights and trends for the UK’s labour market, download the report now!
Latest reports
Report – Golden Triangle UK Life Sciences Labour Market Trends
Golden Triangle - UK Life Sciences Labour Market Trends Report AI and Biotechnology Fuel Golden Triangle Recruitment Growth The UK's Life Sciences sector is entering a new phase of growth, fuelled by investment in biotechnology, artificial intelligence, and...
Report – Accounting & Finance UK Finance Labour Market Trends
Accounting & Finance UK - Finance Labour Market Trends Report Commerce & Industry Drives Accountancy Recruitment Growth UK accountancy hiring is increasingly split between Financial Services and Commerce & Industry. Within Financial Services,...
Commercial – UK Life Sciences Labour Market Trends, May 2026
The UK commercial life sciences sector is expected to enter 2026 with a softer hiring outlook as firms shift from rapid expansion towards cost control and operational efficiency. Commercial vacancies are forecast to decline 1.4% year-on-year following several years of strong growth linked to GLP-1 launches and broader pharmaceutical expansion.
